02. Market & TAM
Sized from the bottom up.
The $6.8T wellness figure is context for the shift. The real number is built store by store, from the U.S. independent pharmacy channel up.
TAM: U.S. independent pharmacy channel
Take the store count, multiply by achievable cash-pay wellness revenue per store (validated in Phase 1), and the product is the total channel opportunity.
SAM: our qualified target universe
Apply our acquisition screen:
- Captive market
- Dominant local share
- Favorable income and demographics
- Prescriber density
- Modern pharmacy management system
- Owner willing to roll and stay
That screen produces a count of qualified anchor targets, and the tuck-in count around them.
SOM: what we underwrite
Phase 1 (2–5 stores) → Phase 2 (Mountain West) → Phase 3 (national): units, members, revenue, EBITDA.
The member-level cross-check
Built from evidenced comparables:
| Input | Basis |
|---|---|
| Active patient panel per store | Scripts filled ÷ scripts per patient |
| Panel → member conversion | The assumption to defend |
| Member ARPU | $79–$299/mo; Hone proves $149/mo cash-pay at 55,000 patients treated |
| Product attach | Mito reports member supplement pricing offsetting 50–75% of membership fee |
What the consumer now wants
Consumers are buying proactive health directly, outside the traditional care pathway:
- Hormone optimization and HRT
- GLP-1s and body composition
- Clinical-grade supplementation
- Skin and aesthetics
- Nutrition, sleep, recovery, cognitive performance
- Peptides (roadmap item with a dated catalyst)
Evidence the demand converts at price: Hone Health has tested 300,000+ patients and treated 55,000 at $149/month cash-pay, on $39M raised. Function Health, Superpower, Mito, and OneTwenty have all built subscription businesses on biomarker panels in the last three years.
Consumers want proactive, measured, continuous care. The current system is built and reimbursed to treat disease, not to optimize health.
Same insight, fundable framing, and it makes us a partner to physicians rather than a competitor.
The market is fragmented and untrusted
Today a motivated consumer assembles their own stack:
| Need | Where they go now |
|---|---|
| Labs | Function, Quest direct, or nowhere |
| Supplements | Amazon; no verification, no clinician |
| Hormones / peptides | Telehealth clinics or gray-market vendors |
| Nutrition | |
| Prescriptions | Their pharmacy; disconnected from all of the above |
Nobody owns the whole relationship. Nobody holds the patient's medication data, lab data, and nutrition data in one place. And nobody has a licensed professional the consumer already trusts standing twenty feet away.